International Consolidated Companies (OTC: INCC) Shareholder Update on St. James Remedies (SJR)

NAPLES, FL / ACCESSWIRE / April 29, 2016 / International Consolidated Companies (OTC: INCC) shareholder update on St. James Remedies (SJR).

SJR has executed a letter of intent to joint venture with Reakiro Labs LTD, a UK based producer of Natural, Organic, Bio-Dynamic, phyto-cannabinoid rich, full Entourage effect CBD oil extract. http://www.reakirolabs.com Reakiro, [pronounced Ree A Keer O] which means “Recovery” in Esperanto, has partnered with many “Artisanal Family Farmers” throughout Europe and is sitting on what we believe to be the largest supply (2,000 plus Kilos) of Super High
Quality Hemp Oil Extract in the world.

“We are excited to be working together with REAKIRO to develop new products and delivery systems. By using the best and most consistent quality CBD rich hemp oil extract available, SJR / Reakiro will build a business centered around helping people,” said Antonio Uccello.

“Having had previous experiences with large industrial farms and their inability to produce consistent, clean and vibrant product, Reakiro determined that the only way to get the outstanding results for their customers was to provide them with the best of the best. As such, artisanal family farms are the only way to achieve our mission. We are excited to work with SJR as we are aligned with the same values!” said David Neisingh President, Reakiro Labs LTD.

SJR engaged a South Florida co-packer, who has developed over 800 products, to produce several of its new CBD rich, Hemp Oil Extract products. “We continue our requirement of excellence. We expect to be releasing updates and timelines on our new products starting next month,” said Adam Ardenfriend, President SJR.

SJR is taking an option with Brooks Kelly research, LLC, based in Colorado, on IP (http://www.google.com/patents/US8642645) covering a process to improve bioavailability by allowing absorption through the upper digestive tract, mitigating the first pass metabolism issue that degrades over 90% of active cannabinol thus, optimizing absorption through the upper digestive track. The result of this IP is that the active cannabinoids can last up to 12 hours in vivo and a reduced dosage is possible to achieve the same pain management effects. All of this is accomplished by utilizing food grade ingredients that are generally recognized as safe (GRAS) by the FDA. This IP was developed by Dr. Brooks J. Kelly and includes numerous trade secret product formulations and issued patent and patent application with allowed claims.

“The human body cannot assimilate oils very well. We believe this IP will enable SJR to produce the best, most efficient delivery systems increasing the ability making it, in our opinion, the faster, better solution, while saving money and establishing a cutting edge,” Stated Adam Ardenfriend.

/s/
Adam Ardenfriend, President

/s/
Antonio Uccello, Chairman of the Board

International Consolidated Companies (INCC) was founded in 2002. INCC and its subsidiaries are in the business of people – helping people, through the development of quality hemp products and services, which bring new energy to the world and will ultimately create prosperity for investors. INCC is focused on acquiring and growing businesses that offer innovation, quality, and cost-efficient technologies.

Forward-looking
disclaimer

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risk and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from the statements made herein.

CONTACT:

Adam Ardenfriend, President
305-707-7780
info@stjamesremedies.com

SOURCE: International Consolidated Companies, Inc.

ReleaseID: 439404